Menarini-Stemline Industry Symposium

XPO-1 inhibitors in myeloma: where do we stand?

Saturday, May 13, 2023
09:10–09:55 CEST

R. Rahme
Paris, France
Bio

M. Mohty
Paris, France
Bio

Agenda

09:10-09:30 Pre-clinical evidence for the use of XPO-1 inhibitors in myeloma
R. Rahme, Paris, France
09:30-09:50 Selinexor: the latest clinical data
M. Mohty; Paris, France